https://www.selleckchem.com/pr....oducts/2,4-thiazolid
bound or transiently interacting reductase and oxidase subunits. To examine the outcomes of percutaneous closure of large atrial septal defects (ASDs) (≥25 mm). Data on long-term results after closure of large ASDs are limited. We reviewed the records of 275 consecutive patients who underwent transcatheter closure of large (≥25 mm) ASDs from January 1999 until December 2016 in our center. The most common indication for closure was a large left-to-right shunt. Follow-up (FU) was performed at regular intervals thereafter. Re
Beğen
Yorum Yap
Paylaş
